PremPLI: a machine learning model for predicting the effects of missense mutations on protein-ligand interactions

Abstract

Sun et al. present PremPLI, a machine learning approach and web tool to predict how missense mutations in a drug’s target protein will affect the drug’s binding affinity. PremPLI can be applied to identify drug resistance mechanisms in cancer cells and microorganisms and develop drugs to combat drug resistance.